Jun 01, 2023 8:30am EDT ProPhase Labs’ Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing
May 11, 2023 8:00am EDT ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023
May 08, 2023 8:30am EDT ProPhase Labs hires Dr. Matthew Halpert to Drive Company’s Key Therapeutic and Diagnostic Oncology Programs
May 04, 2023 8:30am EDT ProPhase Labs to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 11:00 a.m. Eastern Time
May 03, 2023 8:30am EDT ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers
Apr 28, 2023 8:30am EDT ProPhase Labs CEO Ted Karkus Named One of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023
Apr 18, 2023 8:00am EDT ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
Mar 28, 2023 8:00am EDT ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
Mar 21, 2023 8:00am EDT ProPhase Labs to Host 2022 Year End Financial Results Conference Call on Tuesday, March 28, 2023 at 11:00 a.m. Eastern Time
